ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1663	National Cancer Institute	Html	en	Childhood Astrocytomas Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood astrocytomas.	cancer treatment 0.624127 new cancer cells 0.50571 high-grade astrocytoma 0.568902 star-shaped brain cells 0.50361 metastatic brain tumors 0.515525 type 0.567046 tuberous sclerosis 0.508341 chemotherapy 0.51254 proton beam radiation 0.504515 PDQ cancer information 0.568694 clinical trial search 0.544652 brain tumors 0.664824 children 0.509721 new blood vessels 0.577461 dead tumor cells 0.517027 clinical trials 0.906249 cancer information summary 0.537035 clinical trial 0.760659 stem cell transplant 0.512502 treatment clinical trial 0.503103 radiation therapy 0.993729 Treatment Editorial Board 0.497213 beam radiation therapy 0.519746 subependymal giant cell 0.530817	treatment 0.904348 general information 0.532617 cancer cells 0.898737 conformal radiation therapy 0.568043 intensity-modulated radiation therapy 0.52166 specific cancer cells 0.501338 stereotactic radiation therapy 0.544315 childhood high-grade astrocytoma 0.500502 astrocytoma 0.619975 low-grade astrocytoma 0.590271 treatment clinical trials 0.531572 National Cancer Institute 0.535683 spinal cord 0.789593 effects cancer treatment 0.512031 new treatment 0.578461 external radiation therapy 0.577741 brain 0.729014 childhood astrocytoma 0.499108 cancer clinical trials 0.564469 checks tumor tissue 0.501876 tumor 0.802924 cancer 0.956922 information 0.571652 childhood low-grade astrocytoma 0.521596	CLICK HERE
1711	National Cancer Institute	Html	en	Breast Cancer Risk in American Women	A fact sheet that provides statistics about a woman’s risk of developing breast cancer and information about breast cancer risk factors.	current incidence rates 0.345094 Physical activity level 0.337892 woman’s risk 0.354657 certain genes 0.34342 breast cancer increases 0.425903 Certain breast changes 0.409974 Mammographic breast density 0.411613 Indian/Alaska Native women 0.346578 breast biopsies 0.390019 Breast Cancer Risk 0.442755 following risk factors 0.34953 close male blood 0.336852 slightly increased risk 0.378351 lifetime risk 0.357498 fatty tissue 0.342031 average American woman 0.385569 fatty tissue increases 0.340815 menopausal hormone therapy 0.39484 current incidence 0.346194 women 0.441907 United States 0.390167 atypical hyperplasia 0.338604 individual woman 0.344493 percent 0.39834	full-term pregnancy 0.359972 breast cancers 0.393892 specific ages 0.341748 dense breasts 0.348222 breast ducts 0.38994 breast tissue 0.419467 National Cancer Institute 0.363645 progestin menopausal hormone 0.339022 higher risk 0.34662 strongest risk factor 0.391772 breast cancer screening 0.434635 recent SEER Cancer 0.368992 breast cancer 0.950607 dense breast tissue 0.413692 annual SEER reports 0.34791 risk factor levels 0.353691 current incidence rate 0.341921 slight changes 0.340621 family history 0.345271 breast cancer incidence 0.450564 risk 0.535827 specific time periods 0.377721 10-year age intervals 0.347265 breast cancer statistics 0.446445	CLICK HERE
1787	National Cancer Institute	Html	es	Prurito (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del prurito (picazón de la piel) como complicación del cáncer y su tratamiento. Se consideran los abordajes de manejo y tratamiento del prurito.	funcionamiento renal 0.688505 cabo pruebas 0.675786 PDQ Prurito 0.877657 siguientes aspectos 0.726626 Diabetes mellitus 0.704562 Physician Data Query 0.887758 distintos tipos 0.680313 Tide Free 0.679893 cuidado personal 0.819492 líquidos suavizantes 0.680081 All Free Clear 0.98679	suficientes líquidos 0.704436 largo plazo 0.693554 medicamentos corticoesteroideos 0.689382 toallitas suavizantes 0.68595 determinada afección 0.743233 National Cancer Institute 0.676484 bastantes líquidos ayuda 0.75946 siguientes riesgos 0.661829 siguientes pruebas 0.722274 ropa all free 0.721127 Instituto Nacional 0.734946	CLICK HERE
1842	National Cancer Institute	Html	es	Tratamiento del cáncer de endometrio (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de endometrio.	Endometrial Cancer Group 0.318951 Obstet Gynecol 0.338539 papillary serous carcinoma 0.328892 uterine papillary serous 0.337487 positive peritoneal cytology 0.310059 with low-risk stage 0.308461 endometrial carcinoma 0.512882 prognostic factors 0.307871 Radiat Oncol Biol 0.365388 surgical staging 0.309654 laparoscopy versus laparotomy 0.308759 oncology group study 0.336362 endometrio estadio 0.314607 prognostic significance 0.310042 Natl Cancer Inst 0.338736 Gynecologic Oncology Group 0.394499 cancer staging 0.313796 Gynecol Oncol 0.593302 patients with 0.367043 radiation therapy 0.313526 Braquiterapia vaginal posoperatoria 0.30677 endometrial cancer 0.978339 peritoneal cytology 0.312286 stage-1 endometrial carcinoma 0.31493 cases with carcinoma 0.307561	Operative Radiation Therapy 0.306859 Lancet Oncol 0.306692 with endometrial carcinoma 0.344016 Danish Endometrial Cancer 0.332392 estadio iv 0.31911 estadio ii 0.371493 with surgical stage 0.316597 Cancer Staging Manual 0.308545 Féderation Internationale 0.308609 endometrial carcinoma only 0.316396 Endometrial Cancer Study 0.319041 stage i-ii papillary 0.306581 endometrial carcinoma among 0.316625 Clin Oncol 0.320098 surgical stage 0.327711 Oncol Biol Phys 0.368458 Cancer Genome Atlas 0.314564 estadio iii 0.309959 clinical stage 0.315784 cuello uterino 0.329408 Gynecol Cancer 0.309855 vaginal brachytherapy 0.308102 treated with 0.309769 with or without 0.308543	CLICK HERE
1888	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin en adultos.	siguientes procedimientos 0.457132 células madre 0.773484 sedimentación globular vsg 0.343223 estadio iv 0.386067 siguientes elementos 0.335371 sudores nocturnos 0.52867 Elabora glóbulos 0.342317 siguientes afecciones 0.326701 siguientes especialistas 0.324883 siguientes tipos 0.334479 área cercanos.ampliar linfoma 0.414688 rayos x 0.318853 Hodgkin Lymphoma 0.444389 abdomen).ampliar linfoma 0.405698 enlace drugs approved 0.376199 largo plazo 0.313634 malformaciones congénitas 0.344911 escáner tep 0.32264 ondas sonoras 0.318768 estadio ie 0.448154 efectos tardíos 0.386184 cáncer.ampliar aspiración 0.320544	quimioterapia sistémica 0.399855 National Cancer Institute 0.315084 siguientes riesgos 0.314848 Instituto Nacional 0.326237 PDQ Tratamiento 0.422426 estadio iie 0.390253 líquido incoloro 0.32327 Herpes zóster 0.316049 estadio iiie 0.444346 siguientes problemas 0.333894 estadio e 0.345757 siguientes factores 0.326864 Physician Data Query 0.353006 siguientes subtipos 0.336371 siguientes sitios 0.33013 Leucemia mielógena aguda 0.327537 hodgkin clásico.ampliar célula 0.434672 estadio iiis 0.943901 células formadoras 0.331979 almacena glóbulos 0.343421 siguientes sumarios 0.346893 siguientes pruebas 0.333482	CLICK HERE
1966	National Cancer Institute	Html	es	Tratamiento del cáncer de labio y de cavidad oral (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de labio y de cavidad oral.	medicamentos retinoides 0.568081 siguientes procedimientos 0.97932 siguientes elementos 0.624752 estadio ii 0.723086 rayos x 0.572217 pequeñas marcas 0.537003 estadio ivc 0.583451 necesarios implantes 0.546577 siguientes riesgos 0.500736 malla ayuda 0.53799 Instituto Nacional 0.536147 área pequeña detrás 0.642422 presente sección 0.536306	partes distantes 0.555475 Physician Data Query 0.531283 estadio iii 0.581263 libre uso 0.500877 radioterapia hiperfraccionada 0.899395 cáncer.ampliar radioterapia 0.670655 Cancer Institute 0.499502 siguientes enlaces 0.516515 siguientes pruebas 0.617318 Dientes flojos 0.587562 pequeño espejo 0.576408 siguientes estadios 0.58645	CLICK HERE
2003	National Cancer Institute	Html	es	Tratamiento de los tumores de estroma gastrointestinal (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores de estroma gastrointestinal	Corless CL 0.538141 Gastric stromal sarcoma 0.50605 stromal tumors irrespective 0.50378 Gastrointestinal pacemaker 0.510002 cases with 0.505031 Demetri GD 0.510561 antígeno cd117 0.5043 stromal tumors but 0.503793 Sin embargo 0.508884 KIT-negative gastrointestinal 0.505275 gastrointestinal stromal sarcomas 0.507782 gen kit 0.50569 Cancer Res 0.504191 sclerosing stromal tumors 0.504057 receptor kit 0.508691 with mutational analysis 0.504267 stromal tumor patient 0.504863 Multiple gastrointestinal 0.505317 before imatinib with 0.505687 PDGFRA activating mutations 0.504562 Oncol Rep 0.503948 nervioso autónomo gastrointestinal 0.506079 interstitial cells 0.505694 TEGI primario recién 0.504948 new cases with 0.504631	verdadero tegi 0.504221 stromal tumor occurs 0.504698 gastric stromal tumours 0.506473 microscopic gastrointestinal 0.505987 gastrointestinal tract 0.505493 gastrointestinal stromal tumors 0.979159 Surg Pathol 0.538619 Duensing A 0.505663 tumors have unique 0.505149 molecular genetic study 0.50922 Cancer Staging Manual 0.525628 tirosina cinasa kit 0.507752 tirosina cinasa 0.607449 proteína cinasa 0.508725 Heinrich MC 0.512562 carney triad 0.506455 gastrointestinal stromal tumours 0.529292 with long-term follow-up 0.503857 stromal sarcoma 0.507115 metastatic gastrointestinal 0.505468 NF1-associated gastrointestinal 0.509992 ANNUAL REVIEWS 0.505692 pacemaker cell tumor 0.506911 AJCC Cancer Staging 0.518324	CLICK HERE
2014	National Cancer Institute	Html	es	Aspectos generales de los exámenes de detección del cáncer (PDQ®)–Versión para profesionales de salud	Información sobre la medición de la eficacia de las pruebas de detección del cáncer y la evaluación de la solidez de las pruebas obtenidas en estudios de investigación de detección del cáncer.	Does screening 0.616458 importancia clínica 0.620073 muertes prematuras 0.612815 American Cancer Society 0.649437 Woods WG 0.609081 shared decision-making 0.610684 únicos exámenes 0.617228 Malmo mammographic screening 0.618339 case-control studies 0.618658 Instituto Nacional 0.618095 SEER Program 0.61206 examen tisular 0.612004 patient decision aids 0.642735 Estados Unidos 0.671925 Clin Epidemiol 0.61257 Natl Cancer Inst 0.655145 screening with 0.61747 screening efficacy 0.629033 cancer screening 0.803421 Kramer BS 0.609339 estadio iv 0.624173 Cancer Intervention 0.613844 End Results 0.611945 Evaluating new screening 0.618163 voluntarios sanos 0.610696	Decision Aid Standards 0.609164 sobrediagnóstico resultante 0.608646 diagnosed with 0.611303 decision aid 0.652528 Cancer Facts 0.614043 Day NE 0.608989 datos probatorios indirectos 0.611287 evaluating neuroblastoma screening 0.619704 Welch HG 0.609007 mammography screening 0.616883 cancer screening strategies 0.649219 Intern Med 0.611038 breast cancer screening 0.675789 Clin Oncol 0.611547 Cancer screening among 0.630365 systematic review 0.61189 cáncer surveillance 0.636085 Mass screening 0.616536 cuello uterino 0.611009 Neuroblastoma Screening Project 0.622021 datos probatorios 0.981275 Black WC 0.609219 mejores desenlaces 0.609922 Cancer Screening Trial 0.636288	CLICK HERE
15637	National Cancer Institute	Html	null	Research Funding Mechanisms	The NCI uses grants, cooperative agreements, and contracts to help stimulate and fund cancer research.			CLICK HERE
16257	National Cancer Institute	Html	es	Prevención	La investigación del NCI de prevención va desde identificación de factores ambientales y de estilos de vida que influyen en el riesgo de cáncer hasta la biología de la formación del cáncer y la evaluación para diseminar intervenciones de prevención.	próxima generación 0.432035 Mejor reducción 0.436692 Investigación Nacional Colaborativa 0.455747 Investigación Oncológica 0.43883 Nuevos planteamientos 0.440499 investigación sustancias 0.43567 Estudio Vida Familiar 0.45233 Estados Unidos 0.908876 numerosos factores 0.443836 cabo estudios 0.446295 Cáncer apoya programas 0.610288	cánceres más 0.43473 numerosos estudios 0.443241 posibles terapias 0.437443 Pre-Cancer Atlas 0.437082 el  uso 0.430938 inmensa complejidad 0.437794 amplio rango 0.43275 prevención del cáncer del nci 0.509541 creación de  vacunas 0.467866 prueba formas 0.434098 Estados Unidos gastarán 0.466237	CLICK HERE